Cryoport, Inc. (NASDAQ:CYRX – Get Rating)'s stock price gapped down before the market opened on Thursday . The stock had previously closed at $28.04, but opened at $27.04. Cryoport shares last traded at $27.34, with a volume of 5,413 shares traded.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC increased their price target on shares of Cryoport from $41.00 to $42.00 and gave the stock a "buy" rating in a research note on Tuesday, July 12th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Cryoport has a consensus rating of "Buy" and an average target price of $61.33.

Cryoport Price Performance

The company has a debt-to-equity ratio of 0.73, a quick ratio of 13.69 and a current ratio of 14.21. The business's 50 day simple moving average is $35.74 and its 200-day simple moving average is $31.03. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of -4.42 and a beta of 1.17.

Insider Transactions at Cryoport

In other news, Director Robert J. Hariri sold 2,000 shares of Cryoport stock in a transaction that occurred on Thursday, August 11th. The shares were sold at an average price of $43.29, for a total value of $86,580.00. Following the transaction, the director now directly owns 7,911 shares of the company's stock, valued at $342,467.19. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, Director Robert J. Hariri sold 2,000 shares of the business's stock in a transaction that occurred on Thursday, August 11th. The shares were sold at an average price of $43.29, for a total transaction of $86,580.00. Following the transaction, the director now directly owns 7,911 shares of the company's stock, valued at $342,467.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard J. Berman sold 2,708 shares of the business's stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $43.05, for a total transaction of $116,579.40. Following the completion of the sale, the director now directly owns 107,203 shares of the company's stock, valued at $4,615,089.15. The disclosure for this sale can be found here. 9.70% of the stock is currently owned by insiders.

Institutional Trading of Cryoport

Institutional investors and hedge funds have recently modified their holdings of the company. Roubaix Capital LLC raised its stake in Cryoport by 123.4% during the 1st quarter. Roubaix Capital LLC now owns 164,301 shares of the consumer goods maker's stock valued at $5,736,000 after purchasing an additional 90,745 shares during the last quarter. GW&K Investment Management LLC raised its stake in shares of Cryoport by 3.7% in the 1st quarter. GW&K Investment Management LLC now owns 799,732 shares of the consumer goods maker's stock valued at $27,919,000 after buying an additional 28,415 shares in the last quarter. Bridgewater Associates LP grew its holdings in shares of Cryoport by 15.3% in the 4th quarter. Bridgewater Associates LP now owns 49,706 shares of the consumer goods maker's stock worth $2,941,000 after purchasing an additional 6,591 shares during the last quarter. Miura Global Management LLC grew its holdings in shares of Cryoport by 19.6% in the 4th quarter. Miura Global Management LLC now owns 110,000 shares of the consumer goods maker's stock worth $6,509,000 after purchasing an additional 18,000 shares during the last quarter. Finally, Mirabella Financial Services LLP grew its holdings in shares of Cryoport by 15.3% in the 4th quarter. Mirabella Financial Services LLP now owns 51,114 shares of the consumer goods maker's stock worth $3,024,000 after purchasing an additional 6,774 shares during the last quarter. 90.33% of the stock is currently owned by institutional investors and hedge funds.

About Cryoport

(Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

Read More

• Get a free copy of the StockNews.com research report on Cryoport (CYRX)
• The Institutions Hold On To Darden Restaurants International
• What Steelcase's Earnings Say About the Return to the Office?
• These 3 Big Dividend Payers Also Boast Strong Price Growth
• Is The Golden Age Of Homebuilding Already Over?
• Natural Gas Prices Continue To Rally, These Stocks Should Benefit

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.